Vortex-assisted  ||| S:0 E:16 ||| JJ
liquid-liquid  ||| S:16 E:30 ||| JJ
extraction  ||| S:30 E:41 ||| NNS
combined  ||| S:41 E:50 ||| VBN
with  ||| S:50 E:55 ||| IN
field-amplified  ||| S:55 E:71 ||| JJ
sample  ||| S:71 E:78 ||| NN
injection  ||| S:78 E:88 ||| NN
and  ||| S:88 E:92 ||| CC
sweeping  ||| S:92 E:101 ||| JJ
micellar  ||| S:101 E:110 ||| JJ
electrokinetic  ||| S:110 E:125 ||| JJ
chromatography  ||| S:125 E:140 ||| NN
for  ||| S:140 E:144 ||| IN
improved  ||| S:144 E:153 ||| JJ
determination  ||| S:153 E:167 ||| NN
of  ||| S:167 E:170 ||| IN
β-blockers  ||| S:170 E:181 ||| JJ
in  ||| S:181 E:184 ||| IN
human  ||| S:184 E:190 ||| JJ
urine  ||| S:190 E:196 ||| NNS
A  ||| S:196 E:198 ||| DT
new  ||| S:198 E:202 ||| JJ
micellar  ||| S:202 E:211 ||| FW
electrokinetic  ||| S:211 E:226 ||| FW
chromatography  ||| S:226 E:241 ||| FW
( ||| S:241 E:242 ||| -LRB-
MEKC ||| S:242 E:246 ||| NNP
)  ||| S:246 E:248 ||| -RRB-
method  ||| S:248 E:255 ||| NN
was  ||| S:255 E:259 ||| VBD
developed  ||| S:259 E:269 ||| VBN
and  ||| S:269 E:273 ||| CC
validated  ||| S:273 E:283 ||| NN
for  ||| S:283 E:287 ||| IN
the  ||| S:287 E:291 ||| DT
analysis  ||| S:291 E:300 ||| NN
of  ||| S:300 E:303 ||| IN
carvedilol  ||| S:303 E:314 ||| NN
and  ||| S:314 E:318 ||| CC
propranolol  ||| S:318 E:330 ||| NN
in  ||| S:330 E:333 ||| IN
human  ||| S:333 E:339 ||| JJ
urine  ||| S:339 E:345 ||| NN
samples ||| S:345 E:352 ||| NNS
.  ||| S:352 E:354 ||| .
In  ||| S:354 E:357 ||| IN
this  ||| S:357 E:362 ||| DT
study ||| S:362 E:367 ||| NN
,  ||| S:367 E:369 ||| ,
vortex-assisted  ||| S:369 E:385 ||| JJ
liquid-liquid  ||| S:385 E:399 ||| JJ
extraction  ||| S:399 E:410 ||| NNS
( ||| S:410 E:411 ||| -LRB-
VALLE ||| S:411 E:416 ||| NNP
)  ||| S:416 E:418 ||| -RRB-
coupled  ||| S:418 E:426 ||| VBN
with  ||| S:426 E:431 ||| IN
field-amplified  ||| S:431 E:447 ||| JJ
sample  ||| S:447 E:454 ||| NN
injection  ||| S:454 E:464 ||| NN
and  ||| S:464 E:468 ||| CC
sweeping  ||| S:468 E:477 ||| JJ
was  ||| S:477 E:481 ||| VBD
employed  ||| S:481 E:490 ||| VBN
for  ||| S:490 E:494 ||| IN
biological  ||| S:494 E:505 ||| JJ
sample  ||| S:505 E:512 ||| NN
clean-up  ||| S:512 E:521 ||| JJ
and  ||| S:521 E:525 ||| CC
sensitivity  ||| S:525 E:537 ||| JJ
enhancement  ||| S:537 E:549 ||| NN
in  ||| S:549 E:552 ||| IN
MEKC ||| S:552 E:556 ||| NNP
.  ||| S:556 E:558 ||| .
After  ||| S:558 E:564 ||| IN
VALLE ||| S:564 E:569 ||| NNP
,  ||| S:569 E:571 ||| ,
the  ||| S:571 E:575 ||| DT
urine  ||| S:575 E:581 ||| JJ
samples  ||| S:581 E:589 ||| NNS
were  ||| S:589 E:594 ||| VBD
analyzed  ||| S:594 E:603 ||| VBN
by  ||| S:603 E:606 ||| IN
MEKC ||| S:606 E:610 ||| NNP
.  ||| S:610 E:612 ||| .
Tris-phosphate  ||| S:612 E:627 ||| JJ
buffer  ||| S:627 E:634 ||| NN
( ||| S:634 E:635 ||| -LRB-
60mmolL ||| S:635 E:642 ||| NNP
( ||| S:642 E:643 ||| -LRB-
-1 ||| S:643 E:645 ||| NNP
) ||| S:645 E:646 ||| -RRB-
,  ||| S:646 E:648 ||| ,
pH  ||| S:648 E:651 ||| JJ
2.0 ||| S:651 E:654 ||| CD
)  ||| S:654 E:656 ||| -RRB-
containing  ||| S:656 E:667 ||| VBG
40 ||| S:667 E:669 ||| CD
%  ||| S:669 E:671 ||| NN
( ||| S:671 E:672 ||| -LRB-
v ||| S:672 E:673 ||| FW
/ ||| S:673 E:674 ||| FW
v ||| S:674 E:675 ||| FW
)  ||| S:675 E:677 ||| -RRB-
methanol  ||| S:677 E:686 ||| NN
was  ||| S:686 E:690 ||| VBD
first  ||| S:690 E:696 ||| RB
filled  ||| S:696 E:703 ||| VBN
into  ||| S:703 E:708 ||| IN
an  ||| S:708 E:711 ||| DT
uncoated  ||| S:711 E:720 ||| JJ
fused-silica  ||| S:720 E:733 ||| JJ
capillary  ||| S:733 E:743 ||| NNS
( ||| S:743 E:744 ||| -LRB-
56cm ||| S:744 E:748 ||| NNP
,  ||| S:748 E:750 ||| ,
50µm  ||| S:750 E:755 ||| CD
i.d. ||| S:755 E:759 ||| CD
) ||| S:759 E:760 ||| -RRB-
.  ||| S:760 E:762 ||| .
The  ||| S:762 E:766 ||| DT
pretreated  ||| S:766 E:777 ||| JJ
urine  ||| S:777 E:783 ||| JJ
sample  ||| S:783 E:790 ||| NN
was  ||| S:790 E:794 ||| VBD
loaded  ||| S:794 E:801 ||| VBN
by  ||| S:801 E:804 ||| IN
electrokinetic  ||| S:804 E:819 ||| JJ
injection  ||| S:819 E:829 ||| NN
( ||| S:829 E:830 ||| -LRB-
10kV ||| S:830 E:834 ||| NNP
,  ||| S:834 E:836 ||| ,
250s ||| S:836 E:840 ||| CD
) ||| S:840 E:841 ||| -RRB-
.  ||| S:841 E:843 ||| .
The  ||| S:843 E:847 ||| DT
stacking  ||| S:847 E:856 ||| NN
and  ||| S:856 E:860 ||| CC
separation  ||| S:860 E:871 ||| NN
were  ||| S:871 E:876 ||| VBD
performed  ||| S:876 E:886 ||| VBN
using  ||| S:886 E:892 ||| VBG
Tris-phosphate  ||| S:892 E:907 ||| JJ
buffer  ||| S:907 E:914 ||| NN
( ||| S:914 E:915 ||| -LRB-
30mmolL ||| S:915 E:922 ||| NNP
( ||| S:922 E:923 ||| -LRB-
-1 ||| S:923 E:925 ||| NNP
) ||| S:925 E:926 ||| -RRB-
,  ||| S:926 E:928 ||| ,
pH  ||| S:928 E:931 ||| JJ
3.0 ||| S:931 E:934 ||| CD
)  ||| S:934 E:936 ||| -RRB-
containing  ||| S:936 E:947 ||| VBG
30 ||| S:947 E:949 ||| CD
%  ||| S:949 E:951 ||| NN
( ||| S:951 E:952 ||| -LRB-
v ||| S:952 E:953 ||| FW
/ ||| S:953 E:954 ||| FW
v ||| S:954 E:955 ||| FW
)  ||| S:955 E:957 ||| -RRB-
methanol  ||| S:957 E:966 ||| NN
and  ||| S:966 E:970 ||| CC
50mmolL ||| S:970 E:977 ||| NNP
( ||| S:977 E:978 ||| -LRB-
-1 ||| S:978 E:980 ||| NNP
)  ||| S:980 E:982 ||| -RRB-
sodium  ||| S:982 E:989 ||| FW
dodecyl  ||| S:989 E:997 ||| FW
sulfate  ||| S:997 E:1005 ||| FW
( ||| S:1005 E:1006 ||| -LRB-
SDS ||| S:1006 E:1009 ||| NNP
)  ||| S:1009 E:1011 ||| -RRB-
at  ||| S:1011 E:1014 ||| IN
-25kV ||| S:1014 E:1019 ||| CD
.  ||| S:1019 E:1021 ||| .
Detection  ||| S:1021 E:1031 ||| NNP
was  ||| S:1031 E:1035 ||| VBD
carried  ||| S:1035 E:1043 ||| VBN
out  ||| S:1043 E:1047 ||| RP
at  ||| S:1047 E:1050 ||| IN
195  ||| S:1050 E:1054 ||| CD
and  ||| S:1054 E:1058 ||| CC
214nm  ||| S:1058 E:1064 ||| CD
for  ||| S:1064 E:1068 ||| IN
carvedilol  ||| S:1068 E:1079 ||| NN
and  ||| S:1079 E:1083 ||| CC
propranolol ||| S:1083 E:1094 ||| NN
,  ||| S:1094 E:1096 ||| ,
respectively ||| S:1096 E:1108 ||| RB
.  ||| S:1108 E:1110 ||| .
The  ||| S:1110 E:1114 ||| DT
suggested  ||| S:1114 E:1124 ||| JJ
method  ||| S:1124 E:1131 ||| NN
is  ||| S:1131 E:1134 ||| VBZ
linear  ||| S:1134 E:1141 ||| JJ
( ||| S:1141 E:1142 ||| -LRB-
r ||| S:1142 E:1143 ||| LS
( ||| S:1143 E:1144 ||| -LRB-
2 ||| S:1144 E:1145 ||| LS
) ||| S:1145 E:1146 ||| -RRB-
≥0.997 ||| S:1146 E:1152 ||| CD
)  ||| S:1152 E:1154 ||| -RRB-
over  ||| S:1154 E:1159 ||| IN
a  ||| S:1159 E:1161 ||| DT
dynamic  ||| S:1161 E:1169 ||| JJ
range  ||| S:1169 E:1175 ||| NN
of  ||| S:1175 E:1178 ||| IN
0.005-1µgmL ||| S:1178 E:1189 ||| NNP
( ||| S:1189 E:1190 ||| -LRB-
-1 ||| S:1190 E:1192 ||| NNP
)  ||| S:1192 E:1194 ||| -RRB-
in  ||| S:1194 E:1197 ||| IN
urine ||| S:1197 E:1202 ||| NN
.  ||| S:1202 E:1204 ||| .
The  ||| S:1204 E:1208 ||| DT
intra-  ||| S:1208 E:1215 ||| JJ
and  ||| S:1215 E:1219 ||| CC
inter-day  ||| S:1219 E:1229 ||| JJ
relative  ||| S:1229 E:1238 ||| JJ
standard  ||| S:1238 E:1247 ||| JJ
deviation  ||| S:1247 E:1257 ||| NN
and  ||| S:1257 E:1261 ||| CC
relative  ||| S:1261 E:1270 ||| JJ
error  ||| S:1270 E:1276 ||| NN
values  ||| S:1276 E:1283 ||| NNS
of  ||| S:1283 E:1286 ||| IN
the  ||| S:1286 E:1290 ||| DT
method  ||| S:1290 E:1297 ||| NN
were  ||| S:1297 E:1302 ||| VBD
below  ||| S:1302 E:1308 ||| IN
20 ||| S:1308 E:1310 ||| CD
% ||| S:1310 E:1311 ||| NN
,  ||| S:1311 E:1313 ||| ,
which  ||| S:1313 E:1319 ||| WDT
shows  ||| S:1319 E:1325 ||| VBZ
good  ||| S:1325 E:1330 ||| JJ
precision  ||| S:1330 E:1340 ||| NN
and  ||| S:1340 E:1344 ||| CC
accuracy ||| S:1344 E:1352 ||| NN
.  ||| S:1352 E:1354 ||| .
Finally ||| S:1354 E:1361 ||| RB
,  ||| S:1361 E:1363 ||| ,
this  ||| S:1363 E:1368 ||| DT
method  ||| S:1368 E:1375 ||| NN
was  ||| S:1375 E:1379 ||| VBD
successfully  ||| S:1379 E:1392 ||| RB
applied  ||| S:1392 E:1400 ||| VBN
to  ||| S:1400 E:1403 ||| TO
the  ||| S:1403 E:1407 ||| DT
analysis  ||| S:1407 E:1416 ||| NN
of  ||| S:1416 E:1419 ||| IN
real  ||| S:1419 E:1424 ||| JJ
urine  ||| S:1424 E:1430 ||| NN
samples ||| S:1430 E:1437 ||| NNS
.  ||| S:1437 E:1439 ||| .
